πŸ’› Fertility & Health

Fertility After Cancer: Preservation, Options, and Hope

A cancer diagnosis changes everything β€” including, sometimes, the timeline for building a family. Whether you're facing treatment right now or are years past it, here's what you need to know about protecting and rebuilding your fertility.

This article contains affiliate links to books and resources. If you purchase through our links, we may earn a small commission at no extra cost to you.

πŸ’›
The Most Important Thing to Know
If you've just been diagnosed, ask about fertility preservation before starting treatment. The American Society of Clinical Oncology recommends discussing fertility with every patient of reproductive age as early as possible β€” ideally before the first cycle of chemo or radiation. There are options, and there is time, even when it doesn't feel like it.

How Cancer Treatment Affects Fertility

Cancer treatment saves lives. It can also damage the cells and organs responsible for reproduction. Understanding which treatments pose the highest risk helps you and your medical team make informed decisions about preservation.

For Women and People with Ovaries

Your ovaries contain a finite supply of eggs β€” you were born with all the eggs you'll ever have. Cancer treatments can damage or destroy these eggs, reduce ovarian reserve, or disrupt the hormonal signaling that drives ovulation. The impact depends on several factors:

For Men and People with Testes

Sperm production is continuous (unlike the fixed egg supply), which means it can often recover after treatment β€” but not always. Chemotherapy, particularly alkylating agents, can reduce or eliminate sperm production temporarily or permanently. Radiation to the pelvis or testes can damage sperm-producing cells. Surgery that removes or damages the testes, prostate, or nerves involved in ejaculation directly affects fertility.

πŸ“Š The Numbers: More than 150,000 people under 45 are diagnosed with cancer annually in the United States. Up to 80% of adolescent and young adult cancer patients experience reduced fertility after treatment. Yet only about half report receiving adequate oncofertility counseling before their treatment began, according to a study published in JAMA Network Open.

Fertility Preservation: Options Before Treatment

If you're reading this before starting cancer treatment, you have the most options. The gold standard recommendation from ASCO (updated in 2025) is to discuss fertility preservation with a reproductive endocrinologist as early as possible after diagnosis.

πŸ₯š Egg Freezing

$9,000–$16,000 per cycle + $500–$1,000/year storage

Ovarian stimulation with hormones over 10–14 days, followed by egg retrieval under sedation. Eggs are vitrified (flash-frozen) and stored. Can typically be completed before treatment begins. Oncofertility patients produce comparable oocyte numbers to non-cancer patients.

Established

🧬 Embryo Freezing

$10,000–$18,000 per cycle + storage

Same stimulation and retrieval process as egg freezing, but retrieved eggs are fertilized with partner or donor sperm before freezing. Historically has had slightly higher survival rates than unfertilized eggs, though modern vitrification has largely closed this gap.

Established

🧊 Sperm Banking

$300–$1,000 + $300–$500/year storage

One or more semen samples are collected and frozen. Simple, fast, and inexpensive compared to egg freezing. Can be done in a single appointment. Strongly recommended for all males of reproductive age before chemotherapy or radiation.

Established

πŸ«€ Ovarian Tissue Freezing

$10,000–$15,000 + storage

A portion of the ovarian cortex is surgically removed and frozen before treatment, then reimplanted after treatment is complete. No longer considered experimental since 2019. Especially valuable for prepubertal patients who can't undergo ovarian stimulation.

Established (since 2019)

πŸ’Š GnRH Agonists

$200–$500/month during treatment

Medications like leuprolide (Lupron) temporarily suppress ovarian function during chemotherapy, potentially protecting eggs from chemical damage. Evidence is mixed but generally supportive, particularly for breast cancer. Can be used alongside egg freezing.

Supportive therapy

πŸ”¬ In Vitro Maturation (IVM)

Similar to egg freezing

Immature eggs are collected without full ovarian stimulation and matured in the laboratory. Useful when there isn't time for a full stimulation cycle before treatment must begin. No longer considered experimental as of 2021.

Established (since 2021)
⏰ Time Is the Critical Factor

A full egg freezing cycle takes about 10–14 days from start to retrieval. Many oncologists can accommodate a two-week delay before starting treatment. If that window doesn't exist, in vitro maturation (IVM) or ovarian tissue freezing may be faster alternatives. For males, sperm banking can be completed in a single day. The key is to have the conversation with your oncologist immediately β€” even if you're not sure you want children.

After Treatment: Assessing What's Changed

Once your cancer treatment is complete and your oncologist clears you, a reproductive endocrinologist can assess where things stand. For women, this typically includes blood tests for AMH (anti-MΓΌllerian hormone) and FSH (follicle-stimulating hormone) levels, plus an antral follicle count via ultrasound. For men, a semen analysis measures sperm count, motility, and morphology.

The results can fall into a wide range:

You don't have to know today whether you want children. You just have to know you want the option. Preservation keeps the door open β€” you can decide later.

The POSITIVE Trial: Pregnancy After Breast Cancer

For years, one of the most agonizing questions for young breast cancer survivors was whether pausing endocrine therapy (tamoxifen, aromatase inhibitors) to try to get pregnant was safe. These drugs are typically prescribed for 5–10 years after treatment, and pregnancy is contraindicated during their use.

In 2023, the landmark POSITIVE trial published in the New England Journal of Medicine provided an answer. The study enrolled over 500 women under 42 with hormone-receptor-positive early breast cancer who wanted to attempt pregnancy. Participants temporarily paused their endocrine therapy for up to two years.

πŸ“Š POSITIVE Trial Results: At a median follow-up of 41 months, there was no significant increase in breast cancer recurrence among women who paused endocrine therapy compared to a matched external cohort who did not pause. Among those who attempted pregnancy, 74% gave birth. The findings have been widely endorsed by ASCO and incorporated into clinical guidelines, though longer-term follow-up is ongoing.

This doesn't mean pausing treatment is right for everyone β€” it's a deeply personal decision that should be made with your oncologist and reproductive endocrinologist together. But the POSITIVE trial removed one of the biggest fears from the equation: it showed that trying for a baby doesn't appear to increase the risk of the cancer coming back.

Paying for Fertility Preservation

Cost is one of the most significant barriers to fertility preservation for cancer patients. Here's the current landscape:

Insurance Coverage

As of late 2025, 21 states and Washington D.C. mandate that private insurers cover fertility preservation for patients undergoing treatments that may impair fertility. At least five states expanded coverage in 2025 alone. Key states with mandates include Connecticut, Delaware, Illinois, Maryland, New Hampshire, New York, Rhode Island, Colorado, California, and New Jersey, among others.

Even in states without mandates, many insurers will cover fertility preservation when it's documented as medically necessary before gonadotoxic treatment. The critical step: get a written referral from your oncologist that explicitly states fertility preservation is recommended prior to gonadotoxic therapy.

Financial Assistance Programs

LIVESTRONG Fertility

Partners with fertility clinics nationwide to offer discounted or free egg freezing, embryo freezing, and sperm banking for cancer patients. One of the most widely used programs.

The SAMFund

Grants and scholarships for young adult cancer survivors to help with costs of rebuilding life after treatment, including fertility preservation.

Alliance for Fertility Preservation

Maintains a state-by-state guide to insurance mandates and connects patients with financial resources. Tracks legislative efforts across all 50 states.

Medication Assistance

EMD Serono's Compassionate Care and Ferring's HeartBeat programs provide free or reduced-cost fertility medications for cancer patients undergoing preservation.

Family-Building After Cancer: Other Paths

If natural conception isn't possible after treatment, there are other ways to build your family:

What to Do Right Now

Depending on where you are in your cancer journey, here are the specific next steps:

πŸ“‹ If You've Just Been Diagnosed

Tell your oncologist you want to discuss fertility preservation before treatment begins. Ask for a referral to a reproductive endocrinologist. Check if your state mandates insurance coverage. Contact LIVESTRONG Fertility for financial assistance. Time matters β€” have this conversation at your next appointment.

πŸ“‹ If You're Currently in Treatment

If you didn't preserve before treatment, ask your oncologist about GnRH agonist therapy to protect remaining ovarian function during chemo. After treatment, a reproductive endocrinologist can assess your fertility and discuss next steps.

πŸ“‹ If Treatment Is Behind You

Schedule an appointment with a reproductive endocrinologist for a full fertility assessment (AMH, FSH, antral follicle count for women; semen analysis for men). This gives you a clear picture of where things stand. Bring your complete treatment history including drugs, doses, and radiation fields.

Books and Resources

If you want to learn more about navigating fertility through and after cancer treatment, these books offer valuable guidance:

Frequently Asked Questions

Not always. The impact on fertility depends on the type of chemotherapy drugs used, the total dose, and your age at treatment. Alkylating agents like cyclophosphamide carry the highest risk. Some people resume normal fertility after treatment while others experience temporary or permanent damage. Your oncologist can assess your specific risk based on your treatment protocol.
Sperm banking typically costs a few hundred dollars. Egg or embryo freezing ranges from $9,000 to $16,000 per cycle including medications and retrieval, plus $500 to $1,000 per year for storage. As of 2025, 21 states and Washington D.C. mandate insurance coverage for medically necessary fertility preservation. Programs like LIVESTRONG Fertility offer discounted or free cycles for cancer patients at participating clinics.
It depends on where the radiation was directed and the dose. Radiation to the pelvis poses the highest risk to reproductive organs. Radiation to other body areas typically has less impact on fertility. Some patients can conceive naturally after radiation while others need assisted reproduction. A reproductive endocrinologist can assess your ovarian reserve or sperm production after treatment is complete.
Most oncologists recommend waiting at least one to two years after completing treatment. This allows time for medications to clear your system and for your body to recover. For hormone-receptor-positive breast cancer, the wait may be longer due to extended endocrine therapy. The POSITIVE trial showed that temporarily pausing endocrine therapy to pursue pregnancy did not increase short-term recurrence risk, but this decision should be made with your oncology team.
Increasingly, yes. As of 2025, 21 states and Washington D.C. require insurers to cover fertility preservation for patients undergoing treatments that may impair fertility. Even in states without mandates, many insurers cover it when documented as medically necessary. The key is to get a written referral from your oncologist explicitly stating medical necessity before gonadotoxic treatment.
The POSITIVE trial was a landmark international study published in the New England Journal of Medicine in 2023. It enrolled over 500 women under 42 with hormone-receptor-positive early breast cancer who wanted to try to conceive. The study found that temporarily pausing endocrine therapy for up to two years to pursue pregnancy did not increase the short-term risk of breast cancer recurrence. Among those who attempted pregnancy, 74% gave birth.
Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Cancer treatment and fertility preservation decisions are deeply personal and should be made with your oncology team and a reproductive endocrinologist who understands your specific diagnosis and treatment plan. Every cancer is different, and your fertility preservation options depend on your unique medical situation. If you've been recently diagnosed, please talk to your oncologist about a referral to a reproductive specialist before beginning treatment.